How the physical similarity of avatars can influence the learning of emotion regulation strategies in teenagers

The aim of this study is to evaluate the influence of the physical similarity of avatars with the user on emotion regulation strategy training. In this study twenty-four teenagers observed an avatar (either physically similar to the participant or neutral) that gets frustrated with his/her computer, after which he/she applies an emotion regulation strategy (slow breathing). The intensity of the emotional induction and regulation processes was measured using questionnaires and electroencephalogram data. The results show that observing an avatar that is physically similar to the participant has a significantly greater impact on emotional valence and arousal in participants and also induces emotional states that are significantly more intense than when observing a neutral avatar. The results seem to indicate significantly greater activation of specific brain regions that are related to these processes and greater identification with the avatar in terms of both subjective and objective measures in participants that observed an avatar that was physically similar to them. However, there were no significant differences in the sense of presence or the appeal (i.e., satisfaction) to participants regarding the virtual environment. The use of avatars in mental health applications is relatively new and its specific influence is still unknown. We consider this study to be a first step forward in better understanding the use of avatars in mental health applications for youth. This research brings new guidelines to the design of different types of applications in this field in order to achieve greater behavioral changes in youth.Wrzesien, M.; Rodriguez Ortega, A.; Rey, B.; Alcañiz Raya, ML.; Banos, R.; Vara, M. (2015). How the physical similarity of avatars can influence the learning of emotion regulation strategies in teenagers. Computers in Human Behavior. 43:101-111. doi:10.1016/j.chb.2014.09.024S1011114

HTLV-1 infection in solid organ transplant donors and recipients in Spain

Background: HTLV-1 infection is a neglected disease, despite infecting 10–15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated illnesses due to immunosuppression, screening is being widely considered in the transplantation setting. Herein, we report the experience with universal HTLV testing of donors and recipients of solid organ transplants in a survey conducted in Spain. Methods: All hospitals belonging to the Spanish HTLV network were invited to participate in the study. Briefly, HTLV antibody screening was performed retrospectively in all specimens collected from solid organ donors and recipients attended since the year 2008. Results: A total of 5751 individuals were tested for HTLV antibodies at 8 sites. Donors represented 2312 (42.2%), of whom 17 (0.3%) were living kidney donors. The remaining 3439 (59.8%) were recipients. Spaniards represented nearly 80%. Overall, 9 individuals (0.16%) were initially reactive for HTLV antibodies. Six were donors and 3 were recipients. Using confirmatory tests, HTLV-1 could be confirmed in only two donors, one Spaniard and another from Colombia. Both kidneys of the Spaniard were inadvertently transplanted. Subacute myelopathy developed within 1 year in one recipient. The second recipient seroconverted for HTLV-1 but the kidney had to be removed soon due to rejection. Immunosuppression was stopped and 3 years later the patient remains in dialysis but otherwise asymptomatic. Conclusion: The rate of HTLV-1 is low but not negligible in donors/recipients of solid organ transplants in Spain. Universal HTLV screening should be recommended in all donor and recipients of solid organ transplantation in Spain. Evidence is overwhelming for very high virus transmission and increased risk along with the rapid development of subacute myelopath

Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals

Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral therapy. The allograft was removed from the second recipient at month 8 due to rejection and immunosuppressors discontinued. To date, 3 years later, this patient remains infected but asymptomatic. HTLV-1 infection was recognized retrospectively in the donor, a native Spaniard who had sex partners from endemic regions. Our findings call for a reappraisal of screening policies on donor-recipient organ transplantation. Based on the high risk of disease development and the large flux of persons from HTLV-1 endemic regions, pre-transplant HTLV-1 testing should be mandatory in Spain

HTLV-1 infection in solid organ transplant donors and recipients in Spain

HTLV-1 infection is a neglected disease, despite infecting 10-15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated illnesses due to immunosuppression, screening is being widely considered in the transplantation setting. Herein, we report the experience with universal HTLV testing of donors and recipients of solid organ transplants in a survey conducted in Spain. All hospitals belonging to the Spanish HTLV network were invited to participate in the study. Briefly, HTLV antibody screening was performed retrospectively in all specimens collected from solid organ donors and recipients attended since the year 2008. A total of 5751 individuals were tested for HTLV antibodies at 8 sites. Donors represented 2312 (42.2%), of whom 17 (0.3%) were living kidney donors. The remaining 3439 (59.8%) were recipients. Spaniards represented nearly 80%. Overall, 9 individuals (0.16%) were initially reactive for HTLV antibodies. Six were donors and 3 were recipients. Using confirmatory tests, HTLV-1 could be confirmed in only two donors, one Spaniard and another from Colombia. Both kidneys of the Spaniard were inadvertently transplanted. Subacute myelopathy developed within 1 year in one recipient. The second recipient seroconverted for HTLV-1 but the kidney had to be removed soon due to rejection. Immunosuppression was stopped and 3 years later the patient remains in dialysis but otherwise asymptomatic. The rate of HTLV-1 is low but not negligible in donors/recipients of solid organ transplants in Spain. Universal HTLV screening should be recommended in all donor and recipients of solid organ transplantation in Spain. Evidence is overwhelming for very high virus transmission and increased risk along with the rapid development of subacute myelopathy

Economic losses experienced by smallscale farmers in Malawi due to cassava brown streak virus disease

Cassava is an important root crop in Malawi. It is the second most important food crop after maize. It is grown throughout the country as a food security crop, sack/cash crop, and as a staple food crop along the Lake Malawi. Is is a staple for over 39 % of the country’s population. Farmers are not benefiting as much as they might from cassava because they are faced with a number of constraints. These include: - inherent low yielding and late maturing local cultivars - pests and diseases prevalent in the country - low promotion of good cultural practices. The major pests and diseases of cassava in Malawi are, cassava mosaic virus disease (CMD), cassava bacterial blight (CBB), cassava brown streak virus disease (CBSD), cassava green mite (CGM), cassava mealy bug (CM) and termites. The objective of this study was to determine the economic impact of CBSD on the farmers in Malawi where the disease is prevalent. The paper makes the following recommendations: - the cassava research organisations should mount urgent awareness campaigns of the disease and its management for both extension agents and farmers - the cassava research organisations should establish effective collaboration with the extension system on matters of proper cassava husbandry to effectively and efficiently control the disease - they should additionally carry out local collection exercises for cultivars that show CBSD disease resistance in the high disease pressure areas - there is an urgent need for cassava research and extension organisations to multiply cultivars and promising clones that have shown multiple disease resistance and that are widely accepted by farmers for distribution in the heavily affected areas - in collaboration with entrepreneurs, these organisations need to develop and strengthen sustainable seed multiplication and distribution systems as a way of assuring the provision of clean planting material

Transmission of Cassava brown streak virus by Bemisia tabaci (Gennadius)

Two whitefly species, Bemisia afer (Priesner & Hosny) and B. tabaci (Gennadius) were used in transmission experiments with Cassava brown streak virus (CBSV) (Ipomovirus; Potyviridae). Adults of whiteflies were given access to CBSV by containing them in clip cages on CBSV-infected cassava plants. Whiteflies were then transferred, together or separately, to CBSD-susceptible cassava plants of var. 'Albert' in a controlled environment. In glasshouse experiments, whiteflies were caged with CBSV-infected and virus-free cassava plants. Transmission of CBSV was sporadic and occurred in three of seven experiments when inoculated by B. afer and B. tabaci or B. tabaci alone, but not by B. afer alone. However, rate of transmission was low (maximum 22%) even when using high whitefly numbers of up to 120 per target plant. Successful transmission was confirmed by the detection of CBSV by reverse transcription-polymerase chain reaction. Spread of cassava brown streak disease (CBSD) in the field in Tanzania coincided with increases in whitefly numbers; further supporting the evidence that B. tabaci is a vector of CBSV. The results of this study establish for the first time that B. tabaci is the vector of CBSV, similar to other ipomoviruses

Transmission of Cassava brown streak virus by Bemisia tabaci (Gennadius)

Two whitefly species, Bemisia afer (Priesner & Hosny) and B. tabaci (Gennadius) were used in transmission experiments with Cassava brown streak virus (CBSV) (Ipomovirus; Potyviridae). Adults of whiteflies were given access to CBSV by containing them in clip cages on CBSV-infected cassava plants. Whiteflies were then transferred, together or separately, to CBSD-susceptible cassava plants of var. 'Albert' in a controlled environment. In glasshouse experiments, whiteflies were caged with CBSV-infected and virus-free cassava plants. Transmission of CBSV was sporadic and occurred in three of seven experiments when inoculated by B. afer and B. tabaci or B. tabaci alone, but not by B. afer alone. However, rate of transmission was low (maximum 22%) even when using high whitefly numbers of up to 120 per target plant. Successful transmission was confirmed by the detection of CBSV by reverse transcription-polymerase chain reaction. Spread of cassava brown streak disease (CBSD) in the field in Tanzania coincided with increases in whitefly numbers; further supporting the evidence that B. tabaci is a vector of CBSV. The results of this study establish for the first time that B. tabaci is the vector of CBSV, similar to other ipomoviruses

Escalada de conciencia virtual: eficacia y usabilidad de un sistema multiusuario para la rehabilitación de la anosognosia en pacientes con daño cerebral adquirido

Noe Sebastián, E.; Llorens Rodríguez, R.; Colomer Font, C.; Navarro Pérez, M.; Alcañiz Raya, ML.; Ferri Campos, J.; Moliner Muñoz, B. (2013). Escalada de conciencia virtual: eficacia y usabilidad de un sistema multiusuario para la rehabilitación de la anosognosia en pacientes con daño cerebral adquirido. Elsevier. http://hdl.handle.net/10251/65581